Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Other Non Operating Income (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) reported Other Non Operating Income of $2.84 million for Q2 2026, down 58.8% from $6.89 million a year earlier but up 115.2% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Other Non Operating Income (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Other Non Operating Income came in at $11.92 million, down 56.6% year-over-year; for FY2025, it came in at $21.47 million, down 9.6% from FY2024.

  • Other Non Operating Income has a five-year compound annual growth rate of 31.7% (FY2020 to FY2025).
  • By year, Other Non Operating Income came in at $23.75 million in FY2024 (+45.6%), $16.32 million in FY2023, $1.05 million in FY2022 (-5.1%) and $1.1 million in FY2021 (-79.7%).
  • Five-year quarterly Other Non Operating Income spans a low of -$945,000 in Q2 2022 and a high of $7.25 million in Q4 2024.
  • Year over year, Other Non Operating Income has now declined in each of the last four quarters, with an average decline of 9.9% over the last eight quarters.
  • The high point for year-over-year Other Non Operating Income in five years was Q3 2023 (growth of 646.6%); the low point was Q1 2026 (a decline of 80.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.32 million (Q1 2026), $2.43 million (Q4 2025) and $5.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Halozyme Therapeutics 12.53 Bn 11.13 Bn 401.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.84 Mn
Mar 31, 2026 1.32 Mn
Dec 31, 2025 2.43 Mn
Sep 30, 2025 5.33 Mn
Jun 30, 2025 6.89 Mn
Mar 31, 2025 6.82 Mn
Dec 31, 2024 7.25 Mn
Sep 30, 2024 6.47 Mn
Jun 30, 2024 5.03 Mn
Mar 31, 2024 4.99 Mn
Dec 31, 2023 5.36 Mn
Sep 30, 2023 4.79 Mn
Jun 30, 2023 3.19 Mn
Mar 31, 2023 2.98 Mn
Dec 31, 2022 852,000.00
Sep 30, 2022 641,000.00
Jun 30, 2022 -945,000.00
Mar 31, 2022 498,000.00
Dec 31, 2021 331,000.00
Sep 30, 2021 274,000.00
API Access

Halozyme Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=HALO&period=max&api_key=YOUR_API_KEY